Stockreport

Viracta Therapeutics Announces New Employment Inducement Grants

Viracta Therapeutics, Inc.  (VIRX) 
PDF SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevent [Read more]